Aprea Therapeutics Inc (APRE) Price Prediction & ForecastAPREAprea Therapeutics Inc

Alphio's APRE stock price prediction model matches the current Aprea Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.85 (+1.86%). The 1-week path is $0.88 (+4.45%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Aprea Therapeutics appears to be a good buy right now due to a recent 5-day price increase of 30.97%, suggesting strong momentum. Additionally, the company has a solid cash position of $46.5 million, which is expected to sustain operations until Q1 2028, reducing financial risk. However, the main risk is the negative earnings trend, with a recent EPS of -0.07, indicating ongoing losses. Overall, the combination of positive price movement and financial stability supports a buy recommendation.

Aprea Therapeutics Inc (APRE) last closed at $0.8386, losing -2.50%. These facts feed the 1-day and 1-week APRE price prediction above.